Form 4: Credo Technology Group CFO Daniel W. Fleming Executes Stock Options and Sells Shares
SEC Form 4 Filing
Daniel W. Fleming, CFO of Credo Technology Group Holding Ltd, exercised stock options and sold shares on September 30, 2024, according to a Form 4 filing with the SEC.
Summary
- On September 30, 2024, Daniel W. Fleming, the Chief Financial Officer of Credo Technology Group Holding Ltd, engaged in transactions involving the company's ordinary shares.
- Fleming exercised employee stock options to acquire 31,300 shares at $0.275 and 57,082 shares at $2.33.
- Concurrently, Fleming sold 74,288 shares at a weighted average price of $30.8689 and 34,502 shares at a weighted average price of $31.6116.
- Following these transactions, Fleming directly owns 676,386 ordinary shares.
- The sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on July 1, 2024.
Sentiment
Score: 5
Explanation: Neutral sentiment. This is a routine disclosure of insider trading activity. The sales were conducted under a pre-arranged trading plan, suggesting they are not necessarily indicative of management's view on the company's prospects.
Industry Context
This filing reflects insider trading activity, which is a common occurrence in publicly traded companies. Investors often monitor these filings to gain insights into management's perspective on the company's stock and future prospects.
Stakeholder Impact
- Shareholders may interpret the CFO's stock sales in various ways, potentially affecting investor confidence.
- The impact on employees is likely minimal unless the transactions signal a significant shift in the company's outlook.
Key Dates
| Date | Description |
|---|---|
| 05/10/2016 | Date employee stock options were granted (31,300 shares) and are fully vested. |
| 11/16/2020 | Date employee stock options were granted (57,082 shares) and are fully vested. |
| 07/01/2024 | Date the Rule 10b5-1 trading plan was adopted by the reporting person. |
| 09/30/2024 | Date of the transactions: exercising stock options and selling shares. |
| 10/02/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.